✦ LIBER ✦

Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study

✍ Scribed by Narin Apisarnthanarax; Rakhshandra Talpur; Staci Ward; Xiao Ni; Hyung-Woo Kim; Madeleine Duvic

Book ID: 116578431
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 430 KB
Volume: 50
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2003.09.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Extracorporeal photopheresis for the tre

Extracorporeal photopheresis for the treatment of refractory Crohn's disease: Results of an open-label pilot study

✍ Maria T. Abreu; Christian von Tirpitz; Robert Hardi; Martin Kaatz; Gert Van Assc 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB 👁 2 views

## Background: Extracorporeal photopheresis (ecp) is effective in immune-mediated disorders. a prospective, uncontrolled pilot study was conducted to evaluate the safety and efficacy of ecp in patients with active crohn's disease (cd) who were refractory to or intolerant of immunosuppressants and/o

Tu2107 Immunomodulation for Treatment of

Tu2107 Immunomodulation for Treatment of Drug and Device Refractory Gastroparesis: An Open Label Pilot Study of GAD65 Positive Patients

✍ Kedar, Archana; Nikitina, Yana; Martin, Evelyn; Vedanarayanan, Vetta; Abell, Tho 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 316 KB